| Revenue | DKK 14,7M | +5% |
| EBITDA | DKK 6,3M | +8% |
| Net profit | DKK 3,3M | -19% |
| Total assets | DKK 31M | +2% |
| Equity | DKK 27,3M | +1% |
| Employees | 12 | — |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.487 | 11.201 | 9.762 | 10.423 | 13.412 | 12.579 | 11.746 | 11.623 | 11.311 | 5.353 | 13.848 | 13.468 | 13.997 | 14.687 |
| Staff expenses | -10.375 | -9.817 | -9.892 | -8.609 | -10.402 | -9.001 | -6.860 | -6.828 | -7.057 | -7.306 | -7.464 | -6.847 | -8.163 | -8.398 |
| EBITDA | 1.112 | 1.384 | -130 | 1.814 | 3.010 | 3.579 | 4.886 | 4.794 | 4.254 | -1.953 | 6.384 | 6.606 | 5.833 | 6.289 |
| Depreciation & amort. | -3.646 | -3.532 | -3.048 | -2.335 | -2.723 | -2.402 | -2.358 | -2.383 | -806 | -420 | -569 | -1.544 | -1.649 | -2.759 |
| EBIT | -2.534 | -2.148 | -3.179 | -521 | 287 | 1.177 | 2.527 | 2.411 | 3.448 | -2.373 | 5.815 | 5.062 | 4.184 | 3.530 |
| Net financials | -18 | -2 | -25 | 35 | -282 | -133 | -85 | -62 | -41 | -96 | -147 | -163 | -81 | -191 |
| Profit before tax | -2.552 | 2.250 | -3.203 | -486 | 5 | 1.044 | 2.442 | 2.349 | 3.407 | -2.470 | 5.668 | 4.899 | 4.103 | 3.339 |
| Tax | -0 | 2.200 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -2.552 | 50 | -3.203 | -486 | 5 | 1.044 | 2.442 | 2.349 | 3.407 | -2.470 | 5.668 | 4.899 | 4.103 | 3.339 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 32.517 | 32.401 | 28.786 | 28.525 | 20.052 | 20.239 | 22.338 | 21.288 | 23.416 | 29.159 | 29.377 | 26.499 | 30.455 | 30.967 |
| Equity | 29.837 | 29.887 | 26.684 | 26.198 | 16.503 | 16.547 | 17.989 | 19.338 | 21.245 | 18.776 | 24.444 | 24.343 | 26.946 | 27.284 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.680 | 2.514 | 2.102 | 2.327 | 3.550 | 3.692 | 4.349 | 1.950 | 2.171 | 10.383 | 4.933 | 2.156 | 3.510 | 3.682 |
| Total debt | 2.680 | 2.514 | 2.102 | 2.327 | 3.550 | 3.692 | 4.349 | 1.950 | 2.171 | 10.383 | 4.933 | 2.156 | 3.510 | 3.682 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MR Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
TB Management | Management | 2000 | — | — |
SL Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
SS | Audit | 2000 | — | — |
NE Chief Executive Officer | Chief Executive Officer | 2000 | — | — |
MR Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2004 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2000 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2000 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 | |
VECATA INVEST ApS | Company | 10.0% | 10.0% | 2012 |
VIVOSTAT A/S | Company | 25.0% | 25.0% | 2015 |
| Individual | 20.0% | 20.0% | 2009 | |
VÆKSTFONDEN | Company | 15.0% | 10.0% | 2009 |
TSJ Denmark Holding ApS | Company | 100.0% | 100.0% | 2016 |
A/S DANSK ERHVERVSINVESTERING | Company | 15.0% | 25.0% | 2009 |
SUNSTONE LIFE SCIENCE VENTURES FUND I K/S | Company | 25.0% | 10.0% | 2009 |
DANISH BIOTECH SPV I P/S | Company | 10.0% | 0.0% | 2009 |
| Person | Role here | Other companies |
|---|---|---|
| Michael Ruge | Chief Executive Officer | 0 companies |
| Tom Bjerg Lauritzen | Management | 0 companies |
| Sven Lange | Chief Executive Officer | 0 companies |
| Stahlfest, Statsaut. revisor | Audit | 0 companies |
| Niels Erik Holm | Chief Executive Officer | 0 companies |
| Marko Rackovic | Chief Executive Officer | 0 companies |
| Jørgen Axel Thorball | Chairman | 0 companies |
| Viktor Alexander Maier | Board of Directors | 0 companies |
| Jeppe Høier | Board of Directors | 0 companies |
| Dr. Peter Leopold Maier | Chairman | 0 companies |
| Jan Johannes Wøidemann | Board of Directors | 0 companies |
| Iain Wilcock | Board of Directors | 0 companies |
| Christian Laumand Holm | Board of Directors | 0 companies |
| Isabelle de Crémoux | Board of Directors | 0 companies |
| Peter Bent Svejgaard Kristensen | Board of Directors | 0 companies |
| Michael Bo Pålsson | Chairman | 0 companies |
| John Riis Mortensen | Board of Directors | 0 companies |
| Britta Laumand Holm | Board of Directors | 0 companies |
| Hans-Henrik Horsted Eriksen | Board of Directors | 0 companies |
| Magnus Olafsson Corfitzen | Board of Directors | 0 companies |
| Henning Brømsøe Termansen | Board of Directors | 0 companies |
| Niels Hvid | Board of Directors | 0 companies |
| Yves Gerard Avit De Backer | Board of Directors | 0 companies |
| Martin Bitsch | Board of Directors | 0 companies |
| Gudmund Tyge Korsgaard | Chairman | 0 companies |
| Bo Jesper Hansen | Board of Directors | 0 companies |
| Mikael Teller Heé | Board of Directors | 0 companies |
| Flemming Nordahl Honoré | Board of Directors | 0 companies |